For: | Singh P, Kairuz D, Arbuthnot P, Bloom K. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach. World J Gastroenterol 2021; 27(23): 3182-3207 [PMID: 34163105 DOI: 10.3748/wjg.v27.i23.3182] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v27/i23/3182.htm |
Number | Citing Articles |
1 |
Ulrike M. Reiss, Johnny Mahlangu, Tsukasa Ohmori, Margareth C. Ozelo, Alok Srivastava, Lei Zhang. Haemophilia gene therapy—Update on new country initiatives. Haemophilia 2022; 28(S4): 61 doi: 10.1111/hae.14512
|
2 |
Liqiong Yang, Tao Zou, Yao Chen, Yueshui Zhao, Xu Wu, Mingxing Li, Fukuan Du, Yu Chen, Zhangang Xiao, Jing Shen. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma. Hepatology International 2022; 16(4): 741 doi: 10.1007/s12072-022-10351-6
|
3 |
Dylan Kairuz, Prashika Singh, Tiffany Smith, Patrick Arbuthnot, Abdullah Ely, Kristie Bloom. Messenger RNA Therapeutics. RNA Technologies 2022; 13: 157 doi: 10.1007/978-3-031-08415-7_8
|
4 |
Mohube B. Maepa, Abdullah Ely, Anna Kramvis, Kristie Bloom, Kubendran Naidoo, Omphile E. Simani, Tongai G. Maponga, Patrick Arbuthnot. Hepatitis B Virus Research in South Africa. Viruses 2022; 14(9): 1939 doi: 10.3390/v14091939
|
5 |
Mark A. Feitelson, Alla Arzumanyan, Ira Spector, Arvin Medhat. Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B. Biomedicines 2022; 10(9): 2210 doi: 10.3390/biomedicines10092210
|